This US co to buy Allergan for $63 billion

US biopharmacy company AbbVie said on Tuesday it had agreed to buy Allergan, the maker of Botox, in a stock and cash operation worth about $63 billion.

from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News http://bit.ly/2KAVIyP
via IFTTT